Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Morpholinos | 2 | 2018 | 13 | 1.110 |
Why?
|
| Sarcoglycans | 3 | 2019 | 14 | 0.730 |
Why?
|
| MyoD Protein | 2 | 2019 | 16 | 0.660 |
Why?
|
| Cellular Reprogramming | 2 | 2018 | 51 | 0.630 |
Why?
|
| Urine | 2 | 2018 | 96 | 0.620 |
Why?
|
| Alternative Splicing | 2 | 2020 | 220 | 0.580 |
Why?
|
| Dystrophin | 2 | 2019 | 25 | 0.580 |
Why?
|
| Sarcoglycanopathies | 1 | 2018 | 2 | 0.570 |
Why?
|
| Targeted Gene Repair | 1 | 2017 | 1 | 0.550 |
Why?
|
| Muscle Development | 2 | 2019 | 45 | 0.530 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2017 | 39 | 0.520 |
Why?
|
| Hexokinase | 3 | 2012 | 22 | 0.510 |
Why?
|
| Progeria | 1 | 2016 | 5 | 0.490 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2016 | 15 | 0.490 |
Why?
|
| Muscular Diseases | 1 | 2016 | 68 | 0.490 |
Why?
|
| Lamin Type A | 1 | 2016 | 26 | 0.480 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2092 | 0.360 |
Why?
|
| Mutation | 4 | 2018 | 4374 | 0.350 |
Why?
|
| Cytoprotection | 1 | 2010 | 51 | 0.330 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 223 | 0.310 |
Why?
|
| Exons | 3 | 2019 | 454 | 0.290 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2019 | 15 | 0.270 |
Why?
|
| Gene Editing | 2 | 2019 | 52 | 0.270 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2943 | 0.230 |
Why?
|
| Genetic Therapy | 2 | 2018 | 382 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2022 | 33 | 0.190 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2022 | 19 | 0.190 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 107 | 0.180 |
Why?
|
| RNA Splicing | 2 | 2019 | 159 | 0.160 |
Why?
|
| Exocytosis | 1 | 2020 | 110 | 0.160 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2020 | 61 | 0.160 |
Why?
|
| Circadian Clocks | 1 | 2020 | 66 | 0.150 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 2473 | 0.150 |
Why?
|
| Animals | 10 | 2022 | 28945 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 517 | 0.140 |
Why?
|
| Reading Frames | 1 | 2018 | 6 | 0.140 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 84 | 0.140 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 162 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2020 | 286 | 0.140 |
Why?
|
| Immune Tolerance | 1 | 2020 | 385 | 0.130 |
Why?
|
| Glucose | 1 | 2020 | 701 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 444 | 0.130 |
Why?
|
| Muscular Dystrophies | 1 | 2016 | 55 | 0.120 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2016 | 28 | 0.120 |
Why?
|
| Clone Cells | 1 | 2016 | 223 | 0.120 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.120 |
Why?
|
| Myocytes, Cardiac | 3 | 2019 | 324 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 67 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 348 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 201 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2018 | 781 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2015 | 150 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 855 | 0.110 |
Why?
|
| Fibrosis | 4 | 2019 | 246 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2015 | 706 | 0.100 |
Why?
|
| Humans | 8 | 2020 | 96127 | 0.090 |
Why?
|
| Myocardium | 2 | 2015 | 596 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2012 | 122 | 0.090 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 32 | 0.080 |
Why?
|
| Phenotype | 1 | 2017 | 2579 | 0.080 |
Why?
|
| Oxidants | 1 | 2010 | 86 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2010 | 42 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 165 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2010 | 59 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 165 | 0.080 |
Why?
|
| Muscle Proteins | 1 | 2010 | 134 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 188 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2010 | 278 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 286 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 313 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1666 | 0.080 |
Why?
|
| Brain | 1 | 2020 | 2482 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 329 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2019 | 54 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 798 | 0.070 |
Why?
|
| Transfection | 1 | 2010 | 909 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 898 | 0.070 |
Why?
|
| Cell Survival | 1 | 2010 | 1032 | 0.070 |
Why?
|
| Sarcolemma | 2 | 2019 | 32 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2794 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2017 | 9173 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 1645 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 2551 | 0.050 |
Why?
|
| Schwann Cells | 1 | 2022 | 34 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2022 | 66 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2022 | 85 | 0.050 |
Why?
|
| Rats | 2 | 2022 | 4154 | 0.040 |
Why?
|
| Mice | 4 | 2022 | 12562 | 0.040 |
Why?
|
| ARNTL Transcription Factors | 1 | 2020 | 13 | 0.040 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2020 | 6 | 0.040 |
Why?
|
| Guanylate Kinases | 1 | 2020 | 12 | 0.040 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 15 | 0.040 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2020 | 76 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2010 | 3586 | 0.040 |
Why?
|
| Point Mutation | 1 | 2019 | 247 | 0.040 |
Why?
|
| Homeostasis | 1 | 2020 | 467 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 139 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 559 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2020 | 442 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 305 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 2344 | 0.030 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2015 | 21 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 750 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 47 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 81 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 75 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 213 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1322 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2533 | 0.030 |
Why?
|
| Calcium | 1 | 2019 | 1205 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 564 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 750 | 0.030 |
Why?
|
| Obesity | 1 | 2020 | 1034 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 3490 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 483 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1423 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2020 | 1730 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2012 | 73 | 0.020 |
Why?
|
| Pressure | 1 | 2012 | 175 | 0.020 |
Why?
|
| Male | 3 | 2022 | 45870 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 382 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 385 | 0.020 |
Why?
|
| Antioxidants | 1 | 2012 | 233 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 523 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 633 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 52 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 567 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 257 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 265 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2010 | 253 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 1267 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 484 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2010 | 313 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1561 | 0.020 |
Why?
|
| Mitochondria | 1 | 2012 | 623 | 0.020 |
Why?
|
| Neoplasms | 1 | 2020 | 3250 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 5585 | 0.010 |
Why?
|
| Female | 1 | 2022 | 50063 | 0.010 |
Why?
|